Ingela Franck Lissbrant

13PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applications in healthPredictive and prognostic markersData mining and knowledge discoveryDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 13, 2025
Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study.

Charlotte Alverbratt, Fredrik Sandin, Viktor Kolmbäck

|Feb 02, 2022
Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records.

Charlotte Alverbratt, Hanna Vikman, Marie Hjälm Eriksson

|Sep 17, 2021
Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden.

Giuseppe Fallara, Charlotte Alverbratt, Hans Garmo

|Apr 29, 2021
Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic.

Giuseppe Fallara, Fredrik Sandin, Johan Styrke

|Mar 06, 2021
The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries.

Kerri Beckmann, Hans Garmo, Ingela Franck Lissbrant

|Feb 19, 2021
Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden.

Gincy George, Hanna Vikman, Rolf Gedeborg

Pageof 3

Frequent Collaborators

5 joint publications

Hans Garmo

4 joint publications

Giuseppe Fallara

3 joint publications

Pär Stattin

1 joint publications

Yasin Folkvaljon